Gondi Christopher S, Kandhukuri Neelima, Kondraganti Shakuntala, Gujrati Meena, Olivero William C, Dinh Dzung H, Rao Jasti S
Program of Cancer Biology, Department of Biomedical and Therapeutic Sciences, University of Illinois College of Medicine at Peoria, Peoria, IL 61656, USA.
Int J Oncol. 2006 Mar;28(3):633-9.
Cathepsin B and uPAR play key roles in cancer cell migration and invasion. Here, we demonstrate that the simultaneous, siRNA-mediated down-regulation of uPAR and cathepsin B inhibits glioma cell migration and is accompanied by cytoskeletal condensation. We show that the dephosphorylation of cofilin is inhibited by the down-regulation of uPAR alone and, to a lesser extent, by the down-regulation of cathepsin B alone, and that the effect was much higher with the down-regulation of both molecules by pUC. Using FACS analysis and western blotting for the alphaVbeta3 integrin heterodimer, we determined that down-regulating uPAR subsequently causes the down-regulation of the alphaVbeta3 integrin heterodimer. As evidenced by western blot analysis of ERK1/2, pERK1/2, p38MAPK, p-p38MAPK, AKT, pAKT and PI3-k, the MEK and PI3-k pathways are inhibited. From cytoskeleton studies, we observed that the down-regulation of uPAR caused cytoskeletal condensation and that the simultaneous down-regulation of uPAR and cathepsin B was even more effective at inducing cytoskeletal condensation than uPAR alone. Our results demonstrate the relevance of uPAR in cytoskeletal dynamics and the potential of uPAR and cathepsin B as targets in the treatment of malignant gliomas.
组织蛋白酶B和尿激酶型纤溶酶原激活物受体(uPAR)在癌细胞迁移和侵袭中起关键作用。在此,我们证明,通过小干扰RNA(siRNA)同时下调uPAR和组织蛋白酶B可抑制胶质瘤细胞迁移,并伴有细胞骨架凝聚。我们发现,单独下调uPAR可抑制丝切蛋白的去磷酸化,单独下调组织蛋白酶B在较小程度上也有此作用,而通过pUC同时下调这两种分子时效果更显著。使用针对αVβ3整合素异二聚体的荧光激活细胞分选(FACS)分析和蛋白质免疫印迹法,我们确定下调uPAR随后会导致αVβ3整合素异二聚体下调。通过对细胞外信号调节激酶1/2(ERK1/2)、磷酸化ERK1/2(pERK1/2)、p38丝裂原活化蛋白激酶(p38MAPK)、磷酸化p38MAPK(p-p38MAPK)、蛋白激酶B(AKT)、磷酸化AKT(pAKT)和磷脂酰肌醇-3激酶(PI3-k)的蛋白质免疫印迹分析证明,丝裂原活化蛋白激酶/细胞外信号调节激酶(MEK)和PI3-k信号通路受到抑制。从细胞骨架研究中,我们观察到下调uPAR会导致细胞骨架凝聚,并且同时下调uPAR和组织蛋白酶B在诱导细胞骨架凝聚方面比单独下调uPAR更有效。我们的结果证明了uPAR在细胞骨架动力学中的相关性,以及uPAR和组织蛋白酶B作为恶性胶质瘤治疗靶点的潜力。